Skip to main content
Figure 1 | BMC Musculoskeletal Disorders

Figure 1

From: Evaluation of hand bone loss by digital X-ray radiogrammetry as a complement to clinical and radiographic assessment in early rheumatoid arthritis: results from the SWEFOT trial

Figure 1

The proportion of patients with different amount of hand bone loss (HBL) during the first 12 months in each treatment group. Only 4.1% of patients with MTX monotherapy had HBL during the first 12 months (p = 0.01, between MTX monotherapy and randomized groups). The number of patients with HBL in each therapy group: MTX responder: 2/49; Triple therapy: 12/55; MTX + INF: 9/55.

Back to article page